Only way to promote public trust
Pauwels 13 [Eleonore Pauwels is a research scholar with the Synthetic Biology Project within the Science and Technology Innovation Program at the Woodrow Wilson International Center for Scholars, in Washington, DC. https://academic.oup.com/bioscience/article/63/2/79/534322?login=true]//LP
The respondents expressed a strong appetite for more information about synthetic biology. There was a broad consensus that “more should be done to inform the American public” about synthetic biology research. In Hart Research Associates (2009), 9 in 10 of the respondents agreed with this statement, including 73% who strongly agreed. The participants also approached synthetic biology with a sense of tentative support and guarded optimism. Although most did not want to stand in the way of this research, they also did not want to let it proceed without government oversight. In Hart Research Associates (2010), the large majority of the respondents believed that rather than synthetic biology being banned, research and development should move forward with a focus on uncovering possible effects on humans and the environment (63%). Only one in three (33%) respondents supported a ban on synthetic biology research until its implications and risks could be better understood (figure 5). The majority of the participants also felt that when it comes to synthetic biology research, voluntary guidelines do not provide adequate oversight. More than half (52%) of them thought that synthetic biology should be regulated by the federal government, whereas 36% thought that voluntary guidelines developed jointly by industry and government could provide adequate oversight (figure 6). nce again, the focus group data contributed nuanced insights into what the participants saw as the best approaches to managing the risks associated with synthetic biology and what they saw as possible ways of increasing public trust. Here is a comment from a participant: I feel [that federal regulation] is the best approach, because I don't agree with banning [synthetic biology]. Technology should advance, and in order to advance… there's risks with it. Anything that we have today comes at a risk, but… I think of the four [options provided], the federal government would be the best. And I guess it would be more in the spotlight than just some private company and its investors. He continued his explanation by referring to the broad principle of political accountability: “At least…, technically, we choose the government, so if they screw up, we can vote them out of office. And with all of the people on television discussing everything, it's probably harder for the government to whitewash an issue as opposed to a private company.” After having discussed with the participants the best approach to managing the risks associated with synthetic biology, the focus groups' moderator asked questions concerning the ways in which the federal government could work to increase public trust. The concern over the competence of government agencies to regulate synthetic biology brought forward many suggestions that scientists or research institutions needed to participate in oversight along with the regulatory agencies. One of the participants expressed her reason for involving scientists in the regulatory process: “I think [that] they should be part of the team, because they bring so much knowledge and understanding.” In general, keeping regulation above the political fray by involving scientific experts was important for the participants. The participants also spoke about enacting a hybrid approach—a kind of private–public partnership that would lead to a better system of checks and balances. As was mentioned by one of the participants, “I guess I would feel more comfortable if there was a system of checks and balances… like the government. Not that that's my first choice, but it seems like it's the only independent option for checking—a system of checks and balances.” Another participant went even further: “So, we're going to have to set up, I believe, a total new framework of so-called ‘commissions and oversights.’” Another participant mentioned the idea of having a third-party overseeing the industry activity: “Regulation [should include] a third party, an unrelated organization, [to] watch over the industry. And that's why we have them, because they have no interest. They are not connected. They are not getting any profit. They are there to certify or check, independent of those who are making the money.” This idea of a system of checks and balances seemed to be the best way of securing accountability and providing the public with information about the research applications: “The knowledge that should something go wrong, there will be repercussions—the checks and balances thing—just so long as if anything goes wrong, someone will be held accountable. They won't be just buying their way out of it. There will be a nice little way to know.” In a nutshell, what these quantitative and qualitative data tell us is that public perceptions toward synthetic biology are ambivalent: If there is no trace of candid optimism, there is also no unilateral technology rejection. The survey respondents and focus group participants showed enthusiasm for synthetic biology applications when those applications were developed to address societal, medical, and sustainability needs. Tinkering with the DNA of existing or newly designed organisms was seen as a potential concern if this research were to be done without sufficiently funded investigations of its potential risks and long-term implications for humans and the environment. In general, the participants also remained quite skeptical about futuristic technological visions based on hype or technoscientific promises; they supported an allocation of funding for research that would lead to applications that actually meet social and sustainability goals. When it comes to oversight, their priorities were to promote transparency and accountability and to ensure a form of tailored governance in which expertise is accompanied by independent checks and balances and in which diverse knowledge sources might help deal with the uncertainty surrounding a new technology.